Paulo Pimentel Assumpção Selected Research

Paulo Pimentel Assumpção Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 12/2009
22	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2007
10	Carcinogenesis 02/2017 - 06/2010
9	Adenocarcinoma 02/2017 - 11/2007
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2014
3	Gastritis 03/2016 - 07/2012
3	Metaplasia 08/2013 - 01/2011
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2013
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Circulating Neoplastic Cells 03/2018
1	Pathologic Complete Response 01/2017
1	Stomach Diseases 03/2016
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2016
1	Infections 10/2014
1	Genomic Instability 01/2014
1	Lymphatic Metastasis 09/2013
1	Atrophic Gastritis 08/2013
1	Dental Plaque 06/2010
1	Aneuploidy (Aneuploid) 11/2007

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2007
14	Messenger RNA (mRNA)IBA 02/2017 - 01/2011
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2011
3	Histones (Histone)IBA 02/2017 - 07/2014
2	Decitabine FDA Link 01/2022 - 01/2020
2	Histone Deacetylase InhibitorsIBA 02/2017 - 07/2014
2	Hormones (Hormone)IBA 01/2017 - 01/2013
2	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 01/2013
2	Codon (Codons)IBA 01/2017 - 01/2013
2	Biological ProductsIBA 08/2015 - 09/2013
2	UreaseIBA 10/2014 - 06/2010
2	Peroxidase (Myeloperoxidase)IBA 06/2010 - 12/2009
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	X-Box Binding Protein 1IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	XenobioticsIBA 01/2020
1	Circulating Tumor DNAIBA 03/2018
1	ChromatinIBA 02/2017
1	taxaneIBA 01/2017
1	AnthracyclinesIBA 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Glycoproteins (Glycoprotein)IBA 03/2016
1	Cadherins (E-Cadherin)IBA 03/2016
1	Mebendazole (Anti-Worm)FDA Link 12/2015
1	AnthelminticsIBA 12/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2015
1	Galectin 3 (LGALS3)IBA 08/2015
1	antineoplaston A10 (A 10)IBA 04/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Piwi-Interacting RNAIBA 01/2015
1	Virulence Factors (Pathogenicity Factors)IBA 10/2014
1	trichostatin A (A 300)IBA 07/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2014
1	AcetyltransferasesIBA 07/2014
1	theasinensin AIBA 07/2014
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 07/2014
1	NucleophosminIBA 01/2014
1	ProhibitinsIBA 01/2014
1	3' Untranslated Regions (3' UTR)IBA 01/2014
1	18S Ribosomal RNAIBA 11/2013
1	GelatinasesIBA 09/2013
1	Indicators and Reagents (Reagents)IBA 09/2013
1	Phenobarbital (Luminal)FDA Link 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	Immunologic Factors (Immunomodulators)IBA 01/2011
1	HomocysteineIBA 01/2011
1	C-Reactive ProteinIBA 01/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2011
1	Insulin-Like PeptidesIBA 06/2010
1	hydrogen sulfite (bisulfite)IBA 06/2010
1	Insulin-Like Growth Factor Binding Protein 3IBA 06/2010
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2009
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2007
1	DNA ProbesIBA 11/2007

Therapy/Procedure

8	Therapeutics 02/2017 - 05/2007
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2013
2	Neoadjuvant Therapy 01/2017 - 01/2013
1	Gastrectomy 01/2021
1	Combined Modality Therapy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Hepatectomy 01/2020
1	Precision Medicine 03/2018